-
FDA approves Gamifant for macrophage activation syndrome in Still’s disease
Source: Pharmafile Published on 2025-06-30
-
Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development
Source: Pharmafile Published on 2025-06-30
-
Galderma launches clinical trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin
Source: Pharmafile Published on 2025-06-27
-
STENTiT treats first patient with regenerative stent for limb preservation
Source: Pharmafile Published on 2025-06-27
-
Inizio Evoke appoints Kelly Cusumano to drive strategic growth and innovation
Source: Pharmafile Published on 2025-06-27
-
Lexeo Therapeutics, PXV Funds and venBio launch new entity to advance RNA therapies for cardiac diseases
Source: Pharmafile Published on 2025-06-27
-
Defining neighbourhood working: big picture or local lens?
Source: Pharmafile Published on 2025-06-27
-
Unlocking the gateway to ‘precision’ UK market access
Source: Pharmafile Published on 2025-06-27
-
PMGroup/Visions4Health unveil Excellence in Healthcare Partnerships Awards
Source: Pharmafile Published on 2025-06-26
-
CSL Behring’s therapy for hereditary angioedema receives positive assessment in Germany
Source: Pharmafile Published on 2025-06-26
-
FDA grants orphan drug designation to antibody-mediated rejection treatment
Source: Pharmafile Published on 2025-06-26
-
Oxeltis secures €800,000 grant to advance antiviral candidate for emerging tropical viruses
Source: Pharmafile Published on 2025-06-26
-
Roche candidate shows early promise for treating haemophilia A
Source: Pharmafile Published on 2025-06-25
-
Novo Nordisk’s therapy delivers significant weight loss in trial
Source: Pharmafile Published on 2025-06-25
-
Opterion Health strengthens board with appointments of Rice Powell and Mark Hahn
Source: Pharmafile Published on 2025-06-25